Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.
about
Amantadine therapy for chronic hepatitis CNon-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patientsPretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.Hepatitis C: progress and problems.Therapeutic applications of alpha interferon for chronic viral hepatitis in pediatric patients.Influence of viral genotype and level of viremia on the severity of liver injury and the response to interferon therapy in Spanish patients with chronic C infection.Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group.Review article: interferon and hepatitis C--factors predicting therapeutic outcome.The effects of a high dose, short course of interferon on hepatitis C.Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C.Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy.Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices.Prediction of cirrhosis in patients with chronic hepatitis C infection by artificial neural network analysis of virus and clinical factors.Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C.Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant alpha-interferon.Association between human leucocyte antigen-DO polymorphisms and interferon/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study.
P2860
Q27473307-A5D7748C-BFAA-4CE4-8E02-B5AF304A9412Q27478313-82A95B6C-AC49-49CC-9117-BE40952926DCQ27487985-1B74CB1D-1006-49A3-AFF9-3842BDE463C7Q33689607-E6996C56-2F3B-45EE-80B7-4600EBA6ACD8Q34409615-71DCA41A-E7CB-4898-88CD-5B817548EBD4Q36642065-C2C010C9-0857-4FFF-8742-95485C496A7FQ40411325-4D2BF277-B90F-4F8B-844F-30050E19BD6DQ42981181-05AC5C10-0D9D-4C34-84F4-DAFACC5DFE02Q42982311-34B3BE6B-B7A3-4009-B862-35696122DF0EQ42989240-9F227987-BCB0-4104-906C-2D9EE1AC2B23Q42992189-DDEF8D34-99E1-42E2-9B23-63C6D3CC8278Q42993278-24A39359-8258-4156-A8D2-2DB755FF9C5FQ42996606-DD3A2F7A-EEE8-4C1C-BC80-37A5A329025AQ43047084-71FD3BF2-00DE-4D0A-86A3-47D5C0FC9112Q45753676-AAD6C558-ED75-4767-B93B-AE67CF90D8C5Q45768145-E5D7FFDD-B9C5-4189-87C2-AAEE2168CA96Q50571392-355A12F3-4691-4173-ACAB-5EBD17E4C291Q50587062-4C293878-0F65-4003-B9C1-5574DDEA3641Q52589250-AE103872-B347-4670-BFD5-69E5E903DFFA
P2860
Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Prediction of the response of ...... sis of pretreatment variables.
@ast
Prediction of the response of ...... sis of pretreatment variables.
@en
Prediction of the response of ...... sis of pretreatment variables.
@nl
type
label
Prediction of the response of ...... sis of pretreatment variables.
@ast
Prediction of the response of ...... sis of pretreatment variables.
@en
Prediction of the response of ...... sis of pretreatment variables.
@nl
prefLabel
Prediction of the response of ...... sis of pretreatment variables.
@ast
Prediction of the response of ...... sis of pretreatment variables.
@en
Prediction of the response of ...... sis of pretreatment variables.
@nl
P2093
P2860
P356
P1433
P1476
Prediction of the response of ...... ysis of pretreatment variables
@en
P2093
M García-Granero
M P Civeira
S Crisóstomo
P2860
P304
P356
10.1136/GUT.34.12.1714
P407
P577
1993-12-01T00:00:00Z